The workshop on new diagnostics and therapeutics to tackle antimicrobial resistance was held in New Delhi, 12-13 October 2015.
PDF, 553KB, 20 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com . Please tell us what format you need. It will help us if you say what assistive technology you use.
The Indo-UK two-day workshop began with discussing opportunities for drug development research, new diagnostic development, new diagnostic alternatives and ended with various Indo-UK initiatives available to tackle infectious diseases and anti-microbial resistance (AMR).
AMR is a moving target. Conventional mechanisms of drug resistance are being replaced and there are evolving ecological nexuses for horizontal transfer of resistances in the microbial world. While we are trying to understand human behaviour that endangers drug resistance, understanding of drug behaviour is also very crucial.
Having systemic structures and governances in place is very vital to help tackle the issue of AMR. The problem goes beyond technological fixes and eventually commitment and actions on issues like regulation, medical and para-medical education and focus on non-medical determinants as well, would by all means help technology yield its benefits in the long run.